TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2025

US Food and Drug Administration Approval Summary: Imetelstat for Selected Patients With Low- to Intermediate-1 Risk Myelodysplastic Syndromes With Transfusion-Dependent Anemia.

Nina Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.